Aortic Valve Insufficiency, also referred to as aortic regurgitation, manifests as a cardiovascular anomaly where the aortic valve fails to close tightly, permitting the backflow of blood into the left ventricle with each heartbeat. This malfunction impairs the heart's ability to pump blood efficiently, resulting in symptoms like fatigue, shortness of breath, and palpitations. Causes of Aortic Valve Insufficiency range from congenital irregularities and infections to age-related wear and tear on the valve. Accurate and prompt diagnosis, typically achieved through imaging studies and echocardiograms, is crucial for determining the severity of the condition. While medications may suffice for symptom management, severe cases often necessitate surgical interventions, such as aortic valve repair or replacement, to restore optimal cardiac function. Collaborative efforts involving cardiovascular specialists and personalized treatment strategies play a pivotal role in effectively addressing Aortic Valve Insufficiency and enhancing the overall well-being of those affected by this cardiac disorder.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Preservation of Skeletal Muscle Mass During GLP 1 Receptor Agonist Mediated Weight Loss Clinical Determinants Risk Stratification and Evidence Based Mitigation Strategies
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : A Unique Case of Infective Endocarditis: Staphylococcus lugdunensis Infective Endocarditis Presenting as Embolic Occipital Stroke Due to Posterior Mitral Leaflet Perforation
Nuha Hasnain, Royal Preston Hospital, United Kingdom
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation